ID.1
Item
females of ages ≥18 years.
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
core biopsy proven invasive breast cancer or
boolean
C0853879 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
ID.3
Item
core biopsy proven low or intermediate grade dcis.
boolean
C0007124 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
ID.4
Item
tumor less than or equal to 2.0 cm in diameter.
boolean
C0475440 (UMLS CUI [1])
ID.5
Item
no prior surgical treatment for breast cancer within 30 days.
boolean
C0744961 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
ID.6
Item
life expectancy of > 10 years, not including the diagnosis of cancer.
boolean
C0023671 (UMLS CUI [1])
ID.7
Item
ecog performance status of 0-2.
boolean
C1520224 (UMLS CUI [1])
ID.8
Item
informed consent given.
boolean
C0021430 (UMLS CUI [1])
ID.9
Item
multifocal invasive breast cancer patients are eligible. all tumors that are palpable or visualized by uss can be treated.
boolean
ID.10
Item
male subjects.
boolean
C1706180 (UMLS CUI [1])
ID.11
Item
ages < 18 years.
boolean
C0001779 (UMLS CUI [1])
ID.12
Item
breast tumor > 2.0 cm in diameter.
boolean
C0475440 (UMLS CUI [1])
ID.13
Item
evidence of distant metastatic disease.
boolean
C1269798 (UMLS CUI [1])
ID.14
Item
evidence of diffuse calcification suggestive of extensive or multifocal dcis.
boolean
C0007124 (UMLS CUI [1,1])
C1275863 (UMLS CUI [1,2])
ID.15
Item
high grade dcis or presence of comedo-necrosis because these lesions can be associated with invasive breast cancer, which would go undetected if the lesion is entirely destroyed by the rf ablation.
boolean
C0007124 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])